OFFICE NO 5 & 6, 3RD FLOOR,
EARTH ALPHA COMPLEX
VASNA BHAYLI RD, VADODARA
GUJARAT, INDIA
What Are Product Complaint and Recall Responsibilities?
Product complaint responsibilities describe how concerns about a medicine are received, documented, assessed, investigated and answered.
Recall responsibilities describe how organisations coordinate the removal of affected medicines from the distribution chain when a recall is required.
The arrangements should identify:
• Who receives the initial report.
• Who assesses quality concerns.
• Who reviews associated patient safety information.
• Who obtains manufacturing records and investigation findings.
• Who maintains batch-level distribution records.
• Who coordinates regulatory notifications.
• Who communicates with customers.
• Who controls recovered stock.
• Who documents the final outcome.
A written agreement should connect these activities without assuming that one organisation performs every role.
Why Planning These Responsibilities Matters
Oncology medicines can differ in formulation, presentation, storage conditions and handling requirements.
A complaint could concern a leaking vial, damaged blister, incorrect label, missing packaging component or suspected transport deviation. Some reports may also include an adverse event or concern about therapeutic effectiveness.
Not every complaint requires a recall. However, potentially serious concerns need prompt assessment through the appropriate quality, pharmacovigilance and regulatory processes.
Key Benefits:
These agreements support operational coordination. They do not remove or transfer statutory responsibilities.
Identify Each Organisation in the Supply Chain
Before agreeing on procedures, document the parties involved in the proposed supply.
Manufacturer
Identify the legal manufacturer and the manufacturing site responsible for the product.
Clarify how manufacturing records, testing information, retained samples and technical expertise can be accessed during an investigation.
Exporter
Establish whether the exporter manufactures the product or acts as a separate trading organisation.
Where the exporter is an intermediary, confirm how it will obtain manufacturer cooperation and communicate findings to the Brazilian partner.
Importer
Identify the organisation responsible for the proposed importation.
Clarify its role in receiving goods, reviewing shipment records, reporting deviations and coordinating with the other responsible parties.
Distributor
Identify who stores and distributes the product after importation.
Agree how downstream customers, batch quantities and stock movements will be recorded.
Brazilian Registration Holder
For a registered medicine, identify the Brazilian registration holder and involve it in the arrangements.
ANVISA’s recall framework places specified communication obligations on medicine registration holders. The importer, distributor and registration holder should not be assumed to be the same organisation. www.gov.br
Where another authorised supply route is proposed, establish the applicable responsibilities for that route before shipment.
Separate Quality Complaints From Safety Information
A complaint process should distinguish the type of information received while allowing related teams to work together.
Product Quality Complaints
Examples include:
• Damaged containers.
• Leaking closures.
• Incorrect labels.
• Missing tablets or packaging components.
• Unexpected product appearance.
• Suspected contamination.
• Product mix-ups.
• Packaging integrity concerns.
These reports should reach the responsible quality team for assessment.
Safety Reports
A report may describe a suspected adverse reaction, medication error, lack of therapeutic effect or another safety concern.
ANVISA’s VigiMed Empresas guidance describes reporting arrangements for registration holders under RDC 406/2020, as amended by RDC 967/2025. The applicable reporting criteria must be assessed by the responsible pharmacovigilance team. www.gov.br
Reports Involving Both
A complaint describing a product defect and a suspected patient reaction may require parallel quality and safety review.
Do not wait for the quality investigation to finish before forwarding relevant safety information.
Link the records so the teams can exchange findings without losing the original report.
What Buyers Should Include in a Quality Agreement
A quality agreement should explain how the organisations will cooperate throughout the product’s supply lifecycle.
1. Product and Agreement Scope
Identify the products covered using sufficient detail.
Include:
• Product name.
• Active ingredient.
• Strength.
• Dosage form.
• Pack presentation.
• Manufacturer.
• Relevant manufacturing site.
• Destination market.
Explain how additional products, manufacturers or presentations will be brought into the agreement.
2. Responsible Contacts
Provide contacts for:
• Quality assurance.
• Pharmacovigilance.
• Regulatory affairs.
• Warehousing and distribution.
• Manufacturer investigations.
• Recall coordination.
Include backup contacts and urgent escalation arrangements that account for time differences between India and Brazil.
3. Complaint Transfer Timelines
Define timelines for initial notification, acknowledgement, follow-up and investigation updates.
Internal timelines should allow the responsible organisations to meet applicable regulatory deadlines.
An agreed investigation period must not delay urgent escalation, required reporting or protective action.
4. Investigation Responsibilities
Specify who will:
• Review the initial information.
• Request missing details.
• Assess related complaints.
• Examine manufacturing and testing records.
• Arrange sample assessment where appropriate.
• Document findings.
• Approve corrective and preventive actions.
• Communicate the outcome.
Where more than one organisation investigates, identify the coordinating party.
5. Records and Continued Cooperation
Agree on record access, retention, confidentiality and support after the commercial agreement ends.
Products already supplied may generate complaints after the last shipment. Ending the trading relationship should not leave those reports without an agreed response process.
Information to Collect When a Complaint Arrives
A useful complaint record should capture available details without delaying escalation while every field is completed.
Record:
• Product name and presentation.
• Batch or lot number.
• Expiry date.
• Description of the concern.
• Date the issue was noticed.
• Quantity involved.
• Current stock location.
• Relevant storage and transport information.
• Photographs, where available.
• Reporter contact information, where appropriate.
• Associated safety information.
Assign a complaint reference and record when each organisation received the information.
Collect and share personal information only as needed through appropriate secure channels.
A Practical Complaint Escalation Example
Suppose a Brazilian distributor receives a report of a leaking vial from an oncology medicine batch.
The distributor should record the product, batch, quantity, location and available evidence, then escalate the report through the agreed process.
The responsible teams can assess:
• Whether stock containment is needed.
• Whether similar reports exist.
• Whether the concern could affect additional units.
• Whether manufacturing or transport information is relevant.
• Whether patient exposure or an adverse event has been reported.
• Whether regulatory action or a recall assessment is required.
The example illustrates coordination rather than a predetermined outcome. A single complaint does not automatically establish the scope or cause of a defect.
Preserve Evidence for the Investigation
Relevant evidence may include:
• Original packaging.
• Labels and leaflets.
• Photographs.
• Available product samples.
• Shipment monitoring data.
• Delivery records.
• Storage records.
• Related correspondence.
Agree who will preserve the material and how it will be transferred or examined.
Oncology products may require specialised handling. Do not arrange informal sample returns or disposal without appropriate instructions.
Preserve the original complaint even when later information changes the assessment.
Plan Recall Responsibilities Before an Incident
A recall procedure should explain how the parties move from assessment to coordinated action.
Decision and Regulatory Coordination
Identify who coordinates the assessment and how the responsible Brazilian organisation will meet its obligations.
ANVISA’s framework addresses medicine recalls and allows authority-directed action in relevant circumstances. Procedures should accommodate both company-initiated and authority-required action. www.gov.br
Affected Product Identification
Agree how product names, strengths, pack sizes and batch numbers will be matched across records.
Avoid using an abbreviated description that could confuse different presentations.
Customer Notification
Identify who drafts, reviews, approves and distributes communications.
Plan for clear Portuguese-language information appropriate to recipients in Brazil.
Stock Recovery
Define how affected stock will be located, controlled, collected and reconciled.
Final Disposition
Specify who authorises return, destruction or another permitted outcome and what evidence will be retained.
Maintain Batch-Level Distribution Records
Recall planning depends on being able to identify where a batch was supplied.
Useful records include:
• Product and presentation.
• Batch number.
• Expiry date.
• Quantity supplied.
• Dispatch date.
• Receiving organisation.
• Delivery location.
• Subsequent distribution information, where applicable.
Agree how quickly these records can be retrieved.
An invoice identifying a customer may not provide sufficient detail if it does not connect that shipment with the relevant batch.
Reconcile Affected Quantities
During a recall, the organisations should be able to explain the status of affected units.
The reconciliation may distinguish:
• Stock remaining in controlled storage.
• Stock distributed to customers.
• Stock recovered.
• Units already used.
• Units otherwise accounted for.
• Outstanding or unexplained quantities.
Use consistent units. Cartons, packs and individual vials should not be combined without an accurate conversion.
Record unresolved discrepancies and the follow-up actions taken.
Manage Storage and Transport Complaints
A transport deviation requires assessment against the specific product’s requirements.
Not every oncology medicine needs refrigeration. Equally, normal appearance does not establish that a product remained suitable after unsuitable exposure.
Clarify who will:
• Preserve temperature-monitoring records.
• Identify affected batches.
• Establish the duration and extent of the deviation.
• Obtain technical assessment.
• Maintain stock controls pending a decision.
• Authorise and document disposition.
A delivery term or freight agreement alone may not explain all these quality responsibilities.
Agree on Costs Without Delaying Necessary Action
Commercial arrangements should address potential costs such as:
• Investigation and testing.
• Customer communications.
• Product collection.
• Secure storage.
• Return transport.
• Authorised destruction.
• Replacement products or credits.
Explain how costs will be documented and how disagreements will be resolved.
Financial disputes should not delay necessary containment, required reporting or other urgent action.
Consider Supply Continuity
A recall can disrupt product availability.
The parties should establish how they will communicate about:
• Unaffected stock.
• Potential replacement batches.
• Expected shipment timing.
• Authorised replacement arrangements.
• Supply limitations.
Replacement products must undergo the applicable quality and regulatory review.
Changes to an individual patient’s treatment remain the responsibility of the treating healthcare team.
Test the Process With a Recall Exercise
A controlled exercise can reveal gaps before a real event.
For a selected batch, assess whether the organisations can:
Clearly identify the exercise as a simulation and control communications to avoid unnecessary alarm.
Update procedures when contact details, products or distribution arrangements change.
Questions to Ask Before Appointing an Exporter
Before progressing, ask:
Request written arrangements rather than relying solely on general assurances.
Common Planning Mistakes Buyers Should Avoid
Assuming the Exporter Performs Every Role
Identify each organisation and its responsibilities separately.
Waiting for Complete Information Before Escalating
Missing details should trigger follow-up without holding back potentially urgent information.
Treating Every Complaint as a Recall
Assess the evidence and risk through the appropriate process.
Separating Quality and Safety Reports Completely
Some reports require both teams to act.
Relying Only on Commercial Terms
Pricing and delivery terms do not replace complaint and recall procedures.
Leaving Procedures Unchanged
Review contacts, products and distribution arrangements regularly.
Discussing Responsibilities With Zircon Medtech
Buyers approaching Zircon Medtech should request clarification of the manufacturer, proposed supply route and organisations responsible in Brazil.
The discussion should cover complaint contacts, manufacturer investigation support, safety-information exchange, batch traceability and recall cooperation.
Ask for written confirmation of the services and support available for the specific products. Where third parties perform activities, identify them and clarify how information will move between the organisations.
These arrangements should be reviewed alongside product documentation and commercial terms before supply begins.
Preparing for Product Complaints and Recalls
Working with an oncology pharmaceutical exporter to Brazil requires clear arrangements for events that may arise after delivery.
Documented responsibilities, accessible contacts, connected quality and safety processes, and retrievable batch records provide a practical foundation.
Before the first shipment, confirm that the agreements reflect the actual supply chain and support the applicable Brazilian requirements.
Share This News